Potassium Iodide → HCID 178489173, compound

HRID 1432077Notes

Reaction equation

HRID 1432077 reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([CH:26]=[C:27]([OH:29])[CH:28]=1)[CH2:5][NH:6][C:7]([NH2:25])=[N:8][C:9]([C:11]1[C:12]([C:17]2[CH:22]=[CH:21][C:20]([O:23][CH3:24])=[CH:19][CH:18]=2)=[N:13][O:14][C:15]=1[CH3:16])=[O:10].Br[CH2:31][CH2:32][Cl:33].C(=O)([O-])[O-].[Cs+].[Cs+].[I-].[K+]>C1COCC1>[Cl:1][C:2]1[CH:3]=[C:4]([CH:26]=[C:27]([O:29][CH2:31][CH2:32][Cl:33])[CH:28]=1)[CH2:5][NH:6]/[C:7](/[NH2:25])=[N:8]/[C:9]([C:11]1[C:12]([C:17]2[CH:18]=[CH:19][C:20]([O:23][CH3:24])=[CH:21][CH:22]=2)=[N:13][O:14][C:15]=1[CH3:16])=[O:10]

Participants

6

Procedure

The compound of Example 23 (8.3 mg, 0.020 mmol), 1-bromo-2-chloroethane (14 mg, 0.1 mmol), cesium carbonate (13 mg, 0.04 mmol) and potassium iodide (4 mg, 0.024 mmol) were mixed in 1 mL of THF in an 8-mL glass vial. The vial was capped and shaken at RT overnight. The reaction mixture was filtered through Acrodisc Syringe Filter (0.45 μm). Solvent was evaporated in vacuo. The residue was purified by preparative HPLC to give 2.2 mg of the title compound. LC/MS (method A) RT 2.61, MH30 477. 1H NMR (500 MHz, CD3OD) δ 7.60 (d, J=8.2 Hz, 2 H), 7.05 (d, J=8.2 Hz, 2 H), 6.99 (s, 2 H), 6.90 (s, 1 H), 4.53 (s, 2 H), 4.26 (t, J=5.3 Hz, 2 H), 3.86 (t, J=5.3 Hz, 2 H), 3.84 (s, 3 H), 2.66 (s, 3 H).

Workup

  1. customThe vial was capped
  2. filtrationThe reaction mixture was filtered through Acrodisc Syringe
  3. filtrationFilter (0.45 μm)
  4. customSolvent was evaporated in vacuo
  5. customThe residue was purified by preparative HPLC

Sources & evidence

ORD record
ord-bbda1ef7f9214223b3bed069b1c36e50
Source dataset
uspto-grants-2009_11
Patent number
US07612069B2

Reaction notes

Loading…